The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Smoking-related interstitial fibrosis (SRIF). Respiratory bronchiolitis with fibrosis
Publications
Respiratory bronchiolitis with fibrosis. High-resolution computed tomography findings and correlation with pathology.
Annals of the American Thoracic Society 2013 Dec;10;590-601 — 2013 Dec — 590-601
Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases.
Journal of clinical pathology 2013 Oct;66;882-7 — 2013 Oct — 882-7
Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Jan;25 Suppl 1;S68-78 — 2012 Jan — S68-78